A new, implantable nanosensor enables real-time monitoring of levodopa. It may allow dosing challenges in Parkinson's ...

Interim data show substantial improvements in “Good On” time compared to other oral CD/LD therapiesCREXONT delivered ...

Phase 2 results selected as one of only 10 featured presentations in the Poster Tour at the 2025 Parkinson Study Group (PSG) Annual ...

Wilmington, New Castle, Delaware, April 23, 2024 (GLOBE NEWSWIRE) -- Allied Market Research has recently published a report, titled, “Levodopa Market Size, Share, Competitive Landscape and Trend ...

The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to treat Parkinson's disease, Amneal Pharmaceuticals announced Wednesday. The treatment is a ...

Please provide your email address to receive an email when new articles are posted on . Apomorphine sublingual film resulted in greater motor improvement and an increase in responders at earlier time ...

A once-a-week Parkinson’s injection could replace multiple daily pills, thanks to a new slow-release formulation developed by researchers. It promises easier treatment, fewer missed doses, and better ...

A type of supplement known as the "dopamine bean" can contain very high levels of levodopa -- in some cases, higher than prescription formulations used to treat Parkinson's disease, researchers found.

Report in the Journal of Parkinson's Disease presents data from one-year trial on long-term safety, efficacy, and quality of life in advanced PD patients using levodopa-carbidopa intestinal gel ...